Genetic Technologies announces the start of testing operations in the United States for its revolutionary geneType genetic risk assessment product series. GeneType’s multi-patented, clinically validated tests will now be performed by Gene by Gene, a premier specialty genetic laboratory based in Houston, Texas, a state-of-the-art, highly accredited laboratory. Gene by Gene’s ability to process up to 25,000 tests per month greatly increases geneType’s operational capacity in North America. The lab’s location in central US will also shorten the turn-around time for samples sent in from North America. Together with the company’s recent distribution agreement with health and wellness technology leader Stay Healthy, , geneType is poised for exponential growth across North America.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GENE:
- GeneType , Stayhealthy announce distribution agreement for multi-risk test
- GeneType and Stayhealthy Announce Landmark Distribution Agreement for Revolutionary Multi-Risk Test
- Genetic Technologies announces release of Comprehensive Risk Assessment test
- Genetic Technologies, Humanise Health host ‘Know Your Risk’ event
- Genetic Technologies files to sell 30M ordinary shares for holders